Sellas Life Sciences CEO Angelos Stergiou said his company is already on the cusp of an eventual leukemia vaccine, but another game-changing cancer vaccine could emerge thanks to artificial intelligence.
“I think this will be a revolutionary decade for medicine and clinical research,” he said.fox and friends. “
“Where AI comes into play will allow us to do things quickly and it will be more personalized. In other words, if you have a cancer patient, we can use AI to do genome sequencing and with the results, we can create a specific vaccine or treatment , or we can say that this particular treatment works for patients.”
AI-designed drug for inflammatory bowel disease enters human clinical trials: ‘Great need’
How long will it take to develop this technology? Stergiou predicted that the first of specialized vaccines could become available within the next three to four years.
“It’s very important to understand that if you put garbage into this algorithm, you’re going to throw away garbage, so it’s going to take a lot of effort from the medical community to really fit this data set, and it’s going to be an ongoing evolution.”
you have experts and “Some Days of Future Past” writer Mark Beckman also joined “Fox & Friends” on Thursday to call the AI revolution the “era of imagination.”
AI can predict whether cancer treatment will work, experts say: ‘Exciting times in medicine’
Speaking to his hosts on the Bent Couch, he noted that Google’s new AI research system, Amie, is designed to help find rare diseases and act as a co-pilot for doctors.
“They did some research, and Discover these rare diseases The disease is now at a very high level, so doctors will use the disease to help them diagnose. “
Click here to get the Fox News app